Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the plasma levels of CRD007 in patients with
abdominal aortic aneurysms after the administration of single doses of tablets containing 10,
25 and 40 mg CRD007.